Genetic variation in the ATP-binding Cassette Transporter gene ABCG2 (BCRP) in a Swedish population

European Journal of Pharmaceutical Sciences

Volumn 18, Issue 5, 2003, Pages 359-364

  Bäckström, Gunilla ^a   Taipalensuu, Jan ^a   Melhus, Håkan ^a   Brändström, Helena ^a   Svensson, Ann Cathrin ^a   Artursson, Per ^a   Kindmark, Andreas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

ABCG2; ATP binding cassette transporter; BCRP; Genetic variation; SNP; Swedish population

Indexed keywords

DNA; DRUG PRODUCTS; GENETIC ENGINEERING;

GENETIC VARIATIONS;

GENES;

ABC TRANSPORTER;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CPG ISLAND; DNA FLANKING REGION; EXON; GENE; GENE DELETION; GENETIC LINKAGE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRON; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SCREENING; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

EID: 0037386078     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(03)00038-1     Document Type: Article

References (28)

1. Allen J.D., Jackson S.C., Schinkel A.H. A mutation hot spot in the bcrp1 (abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance. Cancer Res. 62:2002;2294-2299.
2. Allikmets R., Schriml L.M., Hutchinson A., Romano-Spica V., Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58:1998;5337-5339.
3. Bailey-Dell K.J., Hassel B., Doyle L.A., Ross D.D. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene(1). Biochim. Biophys. Acta. 1520:2001;234-241.
4. Diestra J.E., Scheffer G.L., Catala I., Maliepaard M., Schellens J.H., Scheper R.J., Germa-Lluch J.R., Izquierdo M.A. Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J. Pathol. 198:2002;213-219.
5. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA. 95:1998;15665-15670.
6. Eng C., Brody L.C., Wagner T.M., Devilee P., Vijg J., Szabo C., Tavtigian S.V., Nathanson K.L., Ostrander E., Frank T.S. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J. Med. Genet. 38:2001;824-833.
7. Fellay J., Marzolini C., Meaden E.R., Back D.J., Buclin T., Chave J.P., Decosterd L.A., Furrer H., Opravil M., Pantaleo G., Retelska D., Ruiz L., Schinkel A.H., Vernazza P., Eap C.B., Telenti A. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet. 359:2002;30-36.
8. Hoffmeyer S., Burk O., von Richter O., Arnold H.P., Brockmoller J., Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M., Brinkmann U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA. 97:2000;3473-3478.
9. Honjo Y., Hrycyna C.A., Yan Q.W., Medina-Perez W.Y., Robey R.W., van De Laar A., Litman T., Dean M., Bates S.E. Acquired mutations in the mxr/bcrp/abcp gene alter substrate specificity in mxr/bcrp/abcp-overexpressing cells. Cancer Res. 61:2001;6635-6639.
10. Iida A., Saito S., Sekine A., Mishima C., Kitamura Y., Kondo K., Harigae S., Osawa S., Nakamura Y. Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8. J. Hum. Genet. 47:2002;285-310.
11. Imai Y., Nakane M., Kage K., Tsukahara S., Ishikawa E., Tsuruo T., Miki Y., Sugimoto Y. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther. 1:2002;611-616.
12. Jonker J.W., Smit J.W., Brinkhuis R.F., Maliepaard M., Beijnen J.H., Schellens J.H., Schinkel A.H. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst. 92:2000;1651-1656.
13. Kim R.B. MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences. Pharmacogenetics. 12:2002;425-427.
14. Kruijtzer C.M., Beijnen J.H., Rosing H., ten Bokkel Huinink W.W., Schot M., Jewell R.C., Paul E.M., Schellens J.H. Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. J. Clin. Oncol. 20:2002;2943-2950.
15. Litman T., Brangi M., Hudson E., Fetsch P., Abati A., Ross D.D., Miyake K., Resau J.H., Bates S.E. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell Sci. 113:2000;2011-2021.
16. Maliepaard M., Scheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C., Schinkel A.H., van De Vijver M.J., Scheper R.J., Schellens J.H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61:2001;3458-3464.
17. Marck C. 'DNA Strider': a 'C' program for the fast analysis of DNA and protein sequences on the Apple Macintosh family of computers. Nucleic Acids Res. 16:1988;1829-1836.
18. Oefner, O.J., Underhill, P.A., 1998. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC). Current Protocols in Human Genetics. John Wiley & Sons, Inc., pp. 7.10.1-7.10.11.
19. Ozvegy C., Litman T., Szakacs G., Nagy Z., Bates S., Varadi A., Sarkadi B. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem. Biophys. Res. Commun. 285:2001;111-117.
20. Robey R.W., Honjo Y., van de Laar A., Miyake K., Regis J.T., Litman T., Bates S.E. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim. Biophys. Acta. 1512:2001;171-182.
21. Ross D.D., Karp J.E., Chen T.T., Doyle L.A. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood. 96:2000;365-368.
22. Sargent J.M., Williamson C.J., Maliepaard M., Elgie A.W., Scheper R.J., Taylor C.G. Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia. Br. J. Haematol. 115:2001;257-262.
23. Schneider, S., Roessli, D., Excoffier, L., 2000. Arlequin ver. 2.000: A software for population genetics data analysis. Genetics and Biometry Laboratory, University of Geneva, Switzerland.
24. Steinbach D., Sell W., Voigt A., Hermann J., Zintl F., Sauerbrey A. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia. 16:2002;1443-1447.
25. Taipalensuu J., Tornblom H., Lindberg G., Einarsson C., Sjoqvist F., Melhus H., Garberg P., Sjostrom B., Lundgren B., Artursson P. Correlation of gene expression of 10 drug efflux proteins of the atp-binding cassette transporter family in normal human jejunum and in human intestinal epithelial caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 299:2001;164-170.
26. Takashima H., Boerkoel C.F., Lupski J.R. Screening for mutations in a genetically heterogeneous disorder: DHPLC versus DNA sequence for mutation detection in multiple genes causing Charcot-Marie-Tooth neuropathy. Genet. Med. 3:2001;335-342.
27. Wadelius M., Yue Q.-Y., Melhus H. Influence of CYP2C9 genotype on warfarin dose. 1st Umeå International Summer Conference on Adverse Drug Reactions, Umeå, Sweden 2001, June 14-15 :2001;37.
28. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7:2001;1028-1034.